Abstract
Multiparametric magnetic resonance imaging is proving to be an excellent tool for detecting aggressive prostate cancers and performing targeted biopsies. Potentially, it will reduce overdetection and underdetection and optimise active surveillance and other aspects of cancer assessment and treatment.
| Original language | English |
|---|---|
| Pages (from-to) | 44-46 |
| Number of pages | 3 |
| Journal | Medicine Today |
| Volume | 18 |
| Issue number | 1 |
| Publication status | Published - Jan 2017 |